<p>不幸的是，对于一些股东来说，<strong>Asteria Corporation</strong>（东京证券交易所代码：3853）的股价在过去三十天内下跌了 27%，延续了近期的痛苦。在过去的 30 天里，这一下跌使得股东们经历了艰难的一年，股价在此期间下跌了 37%。</p>
<p>尽管其股价大幅下跌，但可以说 Asteria 目前的市销率（&#34;P/S&#34;）为 2.2 倍，与日本软件行业的中位数市销率约为 1.9 倍相比，似乎仍然处于&#34;中等水平&#34;。虽然这可能不会引起任何人的注意，但如果市销率没有合理依据，投资者可能会错过潜在的机会或忽视即将到来的失望。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
<p>查看我们对 Asteria 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1163897-ps-multiple-vs-industry-1-dark/1744062099276?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1163897-ps-multiple-vs-industry-1-dark/1744062099276"/></p>
<p>TSE:3853 市销率与行业比较 2025 年 4 月 7 日</p>
<h3>Asteria 最近的表现如何？</h3>
<p>例如，考虑到 Asteria 最近的财务表现不佳，其收入一直在下降。一种可能性是，市销率适中，因为投资者认为该公司可能仍能在不久的将来与更广泛的行业保持一致。如果不是这样，那么现有股东可能会对股价的可行性感到有些紧张。</p>
<p>想要了解公司在收益、收入和现金流方面的全面情况吗？那么我们对 Asteria 的 <strong>免费</strong> 报告将帮助您了解其历史表现。</p>
<h2>Asteria 的收入增长趋势如何？</h2>
<p>您唯一会觉得舒适的情况是，当公司的增长与行业紧密相连时，才会看到像 Asteria 这样的市销率。</p>
<p>回顾一下，去年公司的收入增长并不令人兴奋，出现了令人失望的 22% 的下降。这使得最近三年的表现变得不太理想，尽管如此，整体收入仍然实现了 9.6% 的合理增长。因此，我们可以确认，该公司在这段时间内总体上在收入增长方面做得不错，尽管过程中遇到了一些波折。</p>
<p>与行业相比，行业预计在未来 12 个月内将实现 12% 的增长，公司的增长势头较弱，基于最近的中期年化收入结果。</p>
<p>根据这些信息，我们发现 Asteria 的市销率与行业相对相似。似乎大多数投资者忽视了最近有限的增长率，并愿意为接触该股票支付更高的价格。如果市销率回落到与最近的增长率更为一致的水平，他们可能会为未来的失望埋下伏笔。</p>
<h2>我们可以从 Asteria 的市销率中学到什么？</h2>
<p>随着股价暴跌，Asteria 的市销率看起来与其他软件行业相符。一般来说，我们倾向于将市销率的使用限制在评估市场对公司整体健康状况的看法上。</p>
<p>我们已经确定，Asteria 的平均市销率有些令人惊讶，因为其最近三年的增长低于更广泛的行业预测。当我们看到收入疲软且增长速度低于行业时，我们怀疑股价面临下跌风险，从而使市销率回归到预期水平。如果最近的中期收入趋势持续，股价下跌的可能性将变得相当大，给股东带来风险。</p>
<p>您需要注意风险，例如——<strong>Asteria 有 3 个警告信号</strong>（还有 1 个稍显不快），我们认为您应该了解。</p>
<p>当然，<strong>盈利能力强且有良好盈利增长历史的公司通常是更安全的投资</strong>。因此，您可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司有合理的市盈率并且盈利增长强劲。</p>
<p>如果您想交易 Asteria，请在专业人士信赖的最低成本平台上开设账户，Interactive Brokers。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用、无账户最低限额，以及低至 0.03% 的外汇转换率，远远优于大多数经纪商提供的服务。</p>
<p>赞助内容</p>

3853

<p>Asteria Corporation（东京证券交易所代码：3853）的股价在过去一个月下跌了 27%，一年内下跌了 37%，引发了投资者的担忧。尽管其市销率（P/S）为 2.2 倍，超过行业中位数的 1.9 倍，但公司去年的收入下降了 22%，显示出与行业预计 12% 的增长相比，增长乏力。分析师警告称，如果 Asteria 的收入趋势没有改善，股价可能会继续下跌，给股东带来风险</p>

<p>Unfortunately for some shareholders, the <strong>Asteria Corporation</strong> (TSE:3853) share price has dived 27% in the last thirty days, prolonging recent pain. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 37% in that time.</p>
<div class="lb-trans"><p>不幸的是，对于一些股东来说，<strong>Asteria Corporation</strong>（东京证券交易所代码：3853）的股价在过去三十天内下跌了 27%，延续了近期的痛苦。在过去的 30 天里，这一下跌使得股东们经历了艰难的一年，股价在此期间下跌了 37%。</p>
</div><p>Although its price has dipped substantially, it's still not a stretch to say that Asteria's price-to-sales (or &#34;P/S&#34;) ratio of 2.2x right now seems quite &#34;middle-of-the-road&#34; compared to the Software industry in Japan, where the median P/S ratio is around 1.9x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.</p>
<div class="lb-trans"><p>尽管其股价大幅下跌，但可以说 Asteria 目前的市销率（&#34;P/S&#34;）为 2.2 倍，与日本软件行业的中位数市销率约为 1.9 倍相比，似乎仍然处于&#34;中等水平&#34;。虽然这可能不会引起任何人的注意，但如果市销率没有合理依据，投资者可能会错过潜在的机会或忽视即将到来的失望。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
</div><p>See our latest analysis for Asteria</p>
<div class="lb-trans"><p>查看我们对 Asteria 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1163897-ps-multiple-vs-industry-1-dark/1744062099276" alt="" original-src="https://images.simplywall.st/asset/chart/1163897-ps-multiple-vs-industry-1-dark/1744062099276"/></p>
<p>TSE:3853 Price to Sales Ratio vs Industry April 7th 2025</p>
<div class="lb-trans"><p>TSE:3853 市销率与行业比较 2025 年 4 月 7 日</p>
</div><h3>How Has Asteria Performed Recently?</h3>
<div class="lb-trans"><h3>Asteria 最近的表现如何？</h3>
</div><p>For example, consider that Asteria's financial performance has been poor lately as its revenue has been in decline. One possibility is that the P/S is moderate because investors think the company might still do enough to be in line with the broader industry in the near future. If not, then existing shareholders may be a little nervous about the viability of the share price.</p>
<div class="lb-trans"><p>例如，考虑到 Asteria 最近的财务表现不佳，其收入一直在下降。一种可能性是，市销率适中，因为投资者认为该公司可能仍能在不久的将来与更广泛的行业保持一致。如果不是这样，那么现有股东可能会对股价的可行性感到有些紧张。</p>
</div><p>Want the full picture on earnings, revenue and cash flow for the company? Then our <strong>free</strong> report on Asteria will help you shine a light on its historical performance.</p>
<div class="lb-trans"><p>想要了解公司在收益、收入和现金流方面的全面情况吗？那么我们对 Asteria 的 <strong>免费</strong> 报告将帮助您了解其历史表现。</p>
</div><h2>How Is Asteria's Revenue Growth Trending?</h2>
<div class="lb-trans"><h2>Asteria 的收入增长趋势如何？</h2>
</div><p>The only time you'd be comfortable seeing a P/S like Asteria's is when the company's growth is tracking the industry closely.</p>
<div class="lb-trans"><p>您唯一会觉得舒适的情况是，当公司的增长与行业紧密相连时，才会看到像 Asteria 这样的市销率。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 22%. This has soured the latest three-year period, which nevertheless managed to deliver a decent 9.6% overall rise in revenue. So we can start by confirming that the company has generally done a good job of growing revenue over that time, even though it had some hiccups along the way.</p>
<div class="lb-trans"><p>回顾一下，去年公司的收入增长并不令人兴奋，出现了令人失望的 22% 的下降。这使得最近三年的表现变得不太理想，尽管如此，整体收入仍然实现了 9.6% 的合理增长。因此，我们可以确认，该公司在这段时间内总体上在收入增长方面做得不错，尽管过程中遇到了一些波折。</p>
</div><p>Comparing that to the industry, which is predicted to deliver 12% growth in the next 12 months, the company's momentum is weaker, based on recent medium-term annualised revenue results.</p>
<div class="lb-trans"><p>与行业相比，行业预计在未来 12 个月内将实现 12% 的增长，公司的增长势头较弱，基于最近的中期年化收入结果。</p>
</div><p>With this information, we find it interesting that Asteria is trading at a fairly similar P/S compared to the industry. It seems most investors are ignoring the fairly limited recent growth rates and are willing to pay up for exposure to the stock. They may be setting themselves up for future disappointment if the P/S falls to levels more in line with recent growth rates.</p>
<div class="lb-trans"><p>根据这些信息，我们发现 Asteria 的市销率与行业相对相似。似乎大多数投资者忽视了最近有限的增长率，并愿意为接触该股票支付更高的价格。如果市销率回落到与最近的增长率更为一致的水平，他们可能会为未来的失望埋下伏笔。</p>
</div><h2>What We Can Learn From Asteria's P/S?</h2>
<div class="lb-trans"><h2>我们可以从 Asteria 的市销率中学到什么？</h2>
</div><p>With its share price dropping off a cliff, the P/S for Asteria looks to be in line with the rest of the Software industry. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>随着股价暴跌，Asteria 的市销率看起来与其他软件行业相符。一般来说，我们倾向于将市销率的使用限制在评估市场对公司整体健康状况的看法上。</p>
</div><p>We've established that Asteria's average P/S is a bit surprising since its recent three-year growth is lower than the wider industry forecast. When we see weak revenue with slower than industry growth, we suspect the share price is at risk of declining, bringing the P/S back in line with expectations. If recent medium-term revenue trends continue, the probability of a share price decline will become quite substantial, placing shareholders at risk.</p>
<div class="lb-trans"><p>我们已经确定，Asteria 的平均市销率有些令人惊讶，因为其最近三年的增长低于更广泛的行业预测。当我们看到收入疲软且增长速度低于行业时，我们怀疑股价面临下跌风险，从而使市销率回归到预期水平。如果最近的中期收入趋势持续，股价下跌的可能性将变得相当大，给股东带来风险。</p>
</div><p>You need to take note of risks, for example - <strong>Asteria has 3 warning signs</strong> (and 1 which is a bit unpleasant) we think you should know about.</p>
<div class="lb-trans"><p>您需要注意风险，例如——<strong>Asteria 有 3 个警告信号</strong>（还有 1 个稍显不快），我们认为您应该了解。</p>
</div><p>Of course, <strong>profitable companies with a history of great earnings growth are generally safer bets</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>当然，<strong>盈利能力强且有良好盈利增长历史的公司通常是更安全的投资</strong>。因此，您可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司有合理的市盈率并且盈利增长强劲。</p>
</div><p>If you're looking to trade Asteria, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 Asteria，请在专业人士信赖的最低成本平台上开设账户，Interactive Brokers。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用、无账户最低限额，以及低至 0.03% 的外汇转换率，远远优于大多数经纪商提供的服务。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

Asteria Corporation（TSE:3853）的股票在下跌 27% 之后，可能还会面临更多不利的意外情况